These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 9681593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB.
    N Engl J Med; 2005 Jul 07; 353(1):46-57. PubMed ID: 16000355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States.
    Dahlén GH, Srinivasan SR, Stenlund H, Wattigney WA, Wall S, Berenson GS.
    J Intern Med; 1998 Nov 07; 244(5):417-24. PubMed ID: 9845858
    [Abstract] [Full Text] [Related]

  • 9. Relation between lipoprotein (a) and in vitro oxidation of apolipoprotein B-containing lipoproteins.
    Serdar Z, Sarandöl E, Dirican M, Yeşilbursa D, Serdar A, Tokullugil A.
    Clin Biochem; 2000 Jun 07; 33(4):303-9. PubMed ID: 10936590
    [Abstract] [Full Text] [Related]

  • 10. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
    Levinson SS.
    Ann Clin Lab Sci; 1997 Jun 07; 27(3):185-92. PubMed ID: 9142370
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
    Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F.
    Atherosclerosis; 2002 Jun 07; 162(2):381-9. PubMed ID: 11996958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M, Kiasari AM.
    Clin Chem Lab Med; 2008 Jun 07; 46(5):667-73. PubMed ID: 18598204
    [Abstract] [Full Text] [Related]

  • 20. Measurement of apolipoprotein B-containing lipoproteins for routine clinical laboratory use in cardiovascular disease.
    Levinson SS, Wagner SG.
    Arch Pathol Lab Med; 1992 Dec 07; 116(12):1350-4. PubMed ID: 1456883
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.